The Optimal One-Month Dosing of Lemborexant for Moderate Obstructive Sleep Apnea (OSA) Patients With Low Arousal Threshold
Clinical trial NCT07683442 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07683442
- Sponsor
- Chulalongkorn University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-06-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.